Timothy Ko, Entheon Biomedical
Psychedelic Spotlight Podcast - Un pódcast de Psychedelic Spotlight

Categorías:
CEO of Entheon Biomedical, Timothy Ko, discusses how the company plans to utilize the psychedelic compound, DMT, to treat a variety of addictions.